Author | Suman Kambhampati, MD | OncLive

Author | Suman Kambhampati, MD

Articles

Dr. Kambhampati on Interferon and Novel Agents in MPNs

March 12, 2019

Video

Suman Kambhampati, MD, co-director of the Blood Cancer Center at Sarah Cannon Research Institute, HCA Midwest Health, discusses the role of interferon and emerging novel agents in the treatment of patients with myeloproliferative neoplasms.

Dr. Kambhampati on the Potential of CAR T-Cell Therapy in CLL

March 08, 2019

Video

Suman Kambhampati, MD, co-medical director, Blood Cancer Program, Sarah Cannon Research Institute, discusses the potential of chimeric antigen receptor (CAR) T-cell therapy in chronic lymphocytic leukemia (CLL).

Dr. Kambhampati on Ropeginterferon Alfa-2b in Myeloproliferative Neoplasms

February 28, 2019

Video

Suman Kambhampati, MD, co-director of the Blood Cancer Center at Sarah Cannon Research Institute, HCA Midwest Health, discusses the use of ropeginterferon alfa-2b in myeloproliferative neoplasms (MPNs).

Dr. Kambhampati Discusses Role of Interferon in MPNs

February 26, 2019

Video

Suman Kambhampati, MD, co-director of the Blood Cancer Center at Sarah Cannon Research Institute, HCA Midwest Health, discusses the role of interferon in the treatment of patients with myeloproliferative neoplasms.

x